Pharmicell Co., Ltd.
005690.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
49
Cost of Revenue
33
Gross Profit
16
Gross Margin
32.9%
Operating Income
3
Operating Margin
7.2%
Net Income
5
Net Margin
9.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
7
EBITDA Margin
14.5%
2023
12/31/2023
Revenue
42
Cost of Revenue
31
Gross Profit
11
Gross Margin
26.6%
Operating Income
1
Operating Margin
1.7%
Net Income
3
Net Margin
6.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
15.0%
2022
12/31/2022
Revenue
45
Cost of Revenue
27
Gross Profit
18
Gross Margin
39.6%
Operating Income
7
Operating Margin
14.7%
Net Income
6
Net Margin
13.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
7
EBITDA Margin
14.8%
2021
12/31/2021
Revenue
38
Cost of Revenue
21
Gross Profit
18
Gross Margin
46.1%
Operating Income
6
Operating Margin
15.0%
Net Income
7
Net Margin
18.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
10
EBITDA Margin
25.3%
2020
12/31/2020
Revenue
28
Cost of Revenue
15
Gross Profit
13
Gross Margin
47.1%
Operating Income
5
Operating Margin
19.2%
Net Income
4
Net Margin
13.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
18.8%